About
There are a number of restrictions in medicines allowed (and wash-out periods recommended) for patients on CAR-T Cell therapy at each stage of the pathway (apheresis, lymphodepletion, CAR-T infusion).
Purpose
This guidance has been produced to document useful medication restriction information for CAR-T Cell therapy.
Attachments
- Medication Restrictions for Patients having CAR-T Therapy V5 FINALOpens in a new window · PDF · 473 KB
Update history
- Guidance reviewed and updated to version 5
- Republished
- Published